Lv5
1110 积分 2022-08-30 加入
Efficacy and safety of obinutuzumab on progressive IgA nephropathy: a case series
12小时前
待确认
2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus
9天前
已完结
A randomized controlled non-inferiority trial examined lower dose prednisolone and activated vitamin D in adult minimal change podocytopathy
22天前
已关闭
Serum anti-PLA2R antibodies can be initially absent in idiopathic membranous nephropathy: seroconversion after prolonged follow-up
30天前
已完结
WCN26-7699 B-CELL–TARGETED THERAPY FOR IDIOPATHIC NEPHROTIC SYNDROME: RESULTS OF THE PHASE III, GLOBAL, MULTICENTER INSHORE TRIAL ASSESSING OBINUTUZUMAB VS MYCOPHENOLATE MOFETIL
1个月前
已关闭
Autoantibodies Targeting Nephrin in Podocytopathies
1个月前
已完结
Autoantibody-triggered podocyte membrane budding drives autoimmune kidney disease
1个月前
已完结
P021 Obinutuzumab induces histological remission and deep kidney parenchymal B-cell depletion in patients with lupus nephritis: exploratory analyses from the REGENCY trial
1个月前
已完结
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
1个月前
已完结
Effects of different B-cell-depleting strategies on the lymphatic tissue
1个月前
已完结
皖公网安备34019202002308
